The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Abstract
The ATM protein, encoded by the gene responsible for the human genetic disorder ataxia telangiectasia (A-T), regulates several cellular responses to DNA breaks. ATM shares a phosphoinositide 3-kinase–related domain with several proteins, some of them protein kinases. A wortmannin-sensitive protein kinase activity was associated with endogenous or recombinant ATM and was abolished by structural ATM mutations. In vitro substrates included the translation repressor PHAS-I and the p53 protein. ATM phosphorylated p53 in vitro on a single residue, serine-15, which is phosphorylated in vivo in response to DNA damage. This activity was markedly enhanced within minutes after treatment of cells with a radiomimetic drug; the total amount of ATM remained unchanged. Various damage-induced responses may be activated by enhancement of the protein kinase activity of ATM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ATM phosphorylates p53 on serine 15, enhancing its transcriptional activity (Banin et al, 1998).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Banin et al, 1998
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on serine 20 and inhibits MDM2 binding (Shieh et al, 1997;Banin et al, 1998;Chehab et al, 2000;Shieh et al, 2000).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Banin et al, 1998
In the citing paper
“Several landmark studies showed that DNA double strand breaks induce phosphorylation of p53 S15 by DNA-PK and ATM (Mayo et al, 1997;Shieh et al, 1997;Banin et al, 1998;Prives and Hall, 1999).”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Banin et al, 1998
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on S20, which is a part of the MDM2-binding site (Shieh et al, 1997(Shieh et al, , 2000;;Banin et al, 1998;Chehab et al, 2000).”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Banin et al, 1998
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Self-citationDNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Self-citationOncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,474
Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasia
Barlow, C., Hirotsune, S., Paylor, R. E., Liyanage, M., Eckhaus, M., Collins, F. S., Shiloh, Y., Crawley, J. N., Ried, T., Tagle, D. A., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80086-0 · Cited by 1,465
Self-citationPhosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin
Brunn, G. J., Hudson, C. C., Sekulić, A., Williams, J. M., Hosoi, H., Houghton, P. J., Lawrence, J. C., & Abraham, R. T. (1997) · Science · doi:10.1126/science.277.5322.99 · Cited by 846
DNA damage induces phosphorylation of the amino terminus of p53
Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., & Kastan, M. B. (1997) · Genes & Development · doi:10.1101/gad.11.24.3471 · Cited by 818
Self-citationHartley, K. O., Gell, D. A., Smith, G. C. M., Zhang, H., Divecha, N., Connelly, M. A., Admon, A., Lees‐Miller, S. P., Anderson, C. W., & Jackson, S. P. (1995) · Cell · doi:10.1016/0092-8674(95)90482-4 · Cited by 745
Self-citationBrunn, G. J., Williams, J. M., Sabers, C. J., Wiederrecht, G., Lawrence, J. C., & Abraham, R. T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00911.x · Cited by 715
Control of p70 S6 kinase by kinase activity of FRAP in vivo
Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Shin, T. B., & Schreiber, S. L. (1995) · Nature · doi:10.1038/377441a0 · Cited by 705
Wymann, M. P., Bulgarelli-Leva, G., Zvelebil, M., Pirola, L., Vanhaesebroeck, B., Waterfield, M. D., & Panayotou, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1722 · Cited by 679
PHAS-I as a Link Between Mitogen-Activated Protein Kinase and Translation Initiation
Lin, T.-A., Kong, X., Haystead, T., Pause, A., Belsham, G. J., Sonenberg, N., & Lawrence, J. C. (1994) · Science · doi:10.1126/science.7939721 · Cited by 671
THE GENETIC DEFECT IN ATAXIA-TELANGIECTASIA
Lavin, M. F., & Shiloh, Y. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.177 · Cited by 642
Self-citationKitagawa, M., Higashi, H., Jung, H. K., Suzuki‐Takahashi, I., Ikeda, M., Tamai, K., Kato, J., Segawa, K., Yoshida, E., Nishimura, S., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01097.x · Cited by 596
Self-citationSavitsky, K., Sfez, S., Tagle, D. A., Ziv, Y., Sartiel, A., Collins, F. S., Shiloh, Y., & Rotman, G. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.11.2025 · Cited by 535
Self-citationWortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase
Ui, M., Okada, T., Hazeki, K., & Hazeki, O. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89056-8 · Cited by 520
ATAXIA-TELANGIECTASIA AND THE NIJMEGEN BREAKAGE SYNDROME: Related Disorders But Genes Apart
Shiloh, Y. (1997) · Annual Review of Genetics · doi:10.1146/annurev.genet.31.1.635 · Cited by 482
Self-citationDual roles of ATM in the cellular response to radiation and in cell growth control.Preprint
Xu, Y., & Baltimore, D. (1996) · Genes & Development · doi:10.1101/gad.10.19.2401 · Cited by 407
Foundations in Cancer Research p53 and ATM: Cell Cycle, Cell Death, and Cancer
Morgan, S. E., & Kastan, M. B. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60095-0 · Cited by 301
Predominance of null mutations in ataxia-telangiectasia
Gilad, S. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.4.433 · Cited by 287
Keegan, K. S., Holtzman, D. A., Plug, A. W., Christenson, E., Brainerd, E. E., Flaggs, G., Bentley, N. J., Taylor, E. M., Meyn, M. S., Moss, S. B., et al. (1996) · Genes & Development · doi:10.1101/gad.10.19.2423 · Cited by 283
Genotype-Phenotype Relationships in Ataxia-Telangiectasia and Variants
Gilad, S., Chessa, L., Khosravi, R., Russell, P. S., Galanty, Y., Piane, M., Gatti, R. A., Jorgensen, T. J., Shiloh, Y., & Bar‐Shira, A. (1998) · The American Journal of Human Genetics · doi:10.1086/301755 · Cited by 253
Self-citationRecombinant ATM protein complements the cellular A-T phenotype
Ziv, Y., Bar‐Shira, A., Pecker, I., Russell, P. S., Jorgensen, T. J., Tsarfati, I., & Shiloh, Y. (1997) · Oncogene · doi:10.1038/sj.onc.1201319 · Cited by 240
Self-citationWatters, D. J., Khanna, K. K., Beamish, H., Birrell, G. W., Spring, K. J., Kedar, P. S., Gatei, M. H., Stenzel, D. J., Hobson, K., Kozlov, S., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201037 · Cited by 187
p53 Is Phosphorylated by CDK7-Cyclin H in a p36MAT1-Dependent Manner
Ko, L. J., Shieh, S.-Y., Chen, X., Jayaraman, L., Tamai, K., Taya, Y., Prives, C. L., & Pan, Z. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7220 · Cited by 171
Self-citationBrown, K. D., Ziv, Y., Sadanandan, S., Chessa, L., Collins, F. S., Shiloh, Y., & Tagle, D. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1840 · Cited by 161
Self-citationResponses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family
Hoekstra, M. F. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80125-6 · Cited by 160
Flagged first, then by citations
Research works printed but not linked: 5
- ; R. A. Gatti in The Genetic Basis of Human Cancer B. Vogelstein and K. W. Kinzler Eds. (McGraw-Hill New York 1998) pp. 275–300;
- Lakin N. D., et al., Oncogene 13, 2707 (1996);
- I. H. Goldberg and L. S. Kappen in Enediyne Antibiotics as Antitumor Agents D. B. Borders and T. W. Doyle Eds. (Dekker New York 1995) pp. 327–362.
- Jung M., et al., Cancer Res. 57, 24 (1997).
- Fiscella M., et al., Oncogene 8, 1519 (1993).
Cited by
Sorted by citations
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Self-citationThe first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Metadata
- Authors
- Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., & Ziv, Y.
- Affiliations
- Tel Aviv University (IL)
- Corresponding author
- Shiloh, Y.
- Venue
- Science
- Published
- 1998-09-11
- Volume
- 281
- Issue
- 5383
- Pages
- 1674-1677
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4212962560
- Cited by
- 1,797
- References
- 29
- Citations by year
- 2026: 26 · 2025: 27 · 2024: 24 · 2023: 31 · 2022: 41 · 2021: 47 · 2020: 47 · 2019: 44 · 2018: 44 · 2017: 51 · 2016: 43 · 2015: 49 · 2014: 62 · 2013: 65 · 2012: 57
- FWCI
- 43.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS031763, NS 31763)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- ATM kinase, p53 phosphorylation, DNA damage response, ataxia telangiectasia, protein kinase activity, radiomimetic drugs
- MeSH terms
- Wortmannin, Androstadienes, Ataxia Telangiectasia, Carrier Proteins, Cell Line, DNA Damage, DNA-Binding Proteins, Enzyme Inhibitors, Humans, Mutation, Zinostatin, Phosphoproteins, Phosphorylation, Protein Kinases, Proteins, Recombinant Proteins, Tumor Cells, Cultured, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Tumor Suppressor Proteins, Protein Kinase Inhibitors, Adaptor Proteins, Signal Transducing, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
